Cargando…

Hospital Variation of Spironolactone Use in Patients Hospitalized for Heart Failure in China—The China PEACE Retrospective Heart Failure Study

BACKGROUND: Although aldosterone antagonists improve outcomes in select individuals with heart failure and reduced ejection fraction, studies in the United States have raised concerns about underuse and overuse. Variations in the prescription of aldosterone antagonist in China are unknown. METHODS A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Yuan, Guan, Wenchi, Masoudi, Frederick A., Wang, Bin, He, Guangda, Spertus, John A., Lu, Yuan, Krumholz, Harlan M., Li, Jing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9673705/ https://www.ncbi.nlm.nih.gov/pubmed/36172964 http://dx.doi.org/10.1161/JAHA.122.026300

Ejemplares similares

Characteristics, Management, and Outcomes of Patients Hospitalized for Heart Failure in China: The China PEACE Retrospective Heart Failure Study
por: Yu, Yuan, et al.
Publicado: (2019)

Traditional Chinese Medicine Use in the Treatment of Acute Heart Failure in Western Medicine Hospitals in China: Analysis From the China PEACE Retrospective Heart Failure Study
por: Yu, Yuan, et al.
Publicado: (2019)

The China Patient-centered Evaluative Assessment of Cardiac Events (China PEACE) retrospective heart failure study design
por: Yu, Yuan, et al.
Publicado: (2018)

National Quality Assessment Evaluating Spironolactone Use During Hospitalization for Acute Myocardial Infarction (AMI) in China: China Patient-centered Evaluation Assessment of Cardiac Events (PEACE)-Retrospective AMI Study, 2001, 2006, and 2011
por: Guan, Wenchi, et al.
Publicado: (2015)

The China Patient-centred Evaluative Assessment of Cardiac Events (PEACE) prospective heart failure study design
por: Huang, Xinghe, et al.
Publicado: (2019)

Quality of Care for Patients Hospitalized for Heart Failure in China
por: Gupta, Aakriti, et al.
Publicado: (2020)

Time to hospital arrival among patients with acute myocardial infarction in China: a report from China PEACE prospective study
por: Guan, Wenchi, et al.
Publicado: (2019)

Percutaneous Coronary Intervention in Patients Without Acute Myocardial Infarction in China: Results From the China PEACE Prospective Study of Percutaneous Coronary Intervention
por: Lu, Yuan, et al.
Publicado: (2018)

Multi-Biomarker Points and Outcomes in Patients Hospitalized for Heart Failure: Insights From the China PEACE Prospective Heart Failure Study
por: He, Guangda, et al.
Publicado: (2022)

China PEACE risk estimation tool for in-hospital death from acute myocardial infarction: an early risk classification tree for decisions about fibrinolytic therapy
por: Li, Xi, et al.
Publicado: (2016)

Use of intravenous magnesium sulfate among patients with acute myocardial infarction in China from 2001 to 2015: China PEACE—Retrospective AMI Study
por: Wang, Xianqiang, et al.
Publicado: (2020)

Trends in Cardiac Biomarker Testing in China for Patients with Acute Myocardial Infarction, 2001 to 2011: China PEACE-Retrospective AMI Study
por: Zhan, Lijuan, et al.
Publicado: (2015)

The china patient‐centered evaluative assessment of cardiac events (PEACE) prospective study of percutaneous coronary intervention: Study design
por: Du, Xue, et al.
Publicado: (2016)

National Assessment of Statin Therapy in Patients Hospitalized with Acute Myocardial Infarction: Insight from China PEACE-Retrospective AMI Study, 2001, 2006, 2011
por: Zhang, Lihua, et al.
Publicado: (2016)

Patterns of Use of Angiotensin‐Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Among Patients With Acute Myocardial Infarction in China From 2001 to 2011: China PEACE‐Retrospective AMI Study
por: Liu, Jiamin, et al.
Publicado: (2015)

Trends in Early Aspirin Use Among Patients With Acute Myocardial Infarction in China, 2001–2011: The China PEACE‐Retrospective AMI Study
por: Gao, Yan, et al.
Publicado: (2014)

The Utilization of Spironolactone in Heart Failure Patients at a Tertiary Hospital in Saudi Arabia
por: Alotaibi, Abdulmalik S, et al.
Publicado: (2020)

Postdischarge Environment Following Heart Failure Hospitalization: Expanding the View of Hospital Readmission
por: Hersh, Andrew M., et al.
Publicado: (2013)

Temporal Trends and Hospital Variation in Mineralocorticoid Receptor Antagonist Use in Veterans Discharged With Heart Failure
por: Dev, Sandesh, et al.
Publicado: (2015)

Use, tolerability and compliance of spironolactone in the treatment of heart failure
por: Lachaine, Jean, et al.
Publicado: (2011)

Furosemide and spironolactone doses and hyponatremia in patients with heart failure
por: Velat, Ivan, et al.
Publicado: (2020)

Traditional Chinese Medicine for Acute Myocardial Infarction in Western Medicine Hospitals in China
por: Spatz, Erica S., et al.
Publicado: (2018)

Sex Differences in 1‐Year Health Status Following Percutaneous Coronary Intervention in Patients Without Acute Myocardial Infarction: Results From the China PEACE Prospective Study
por: Zheng, Xin, et al.
Publicado: (2020)

National Quality Assessment of Early Clopidogrel Therapy in Chinese Patients With Acute Myocardial Infarction (AMI) in 2006 and 2011: Insights From the China Patient-Centered Evaluative Assessment of Cardiac Events (PEACE)–Retrospective AMI Study
por: Zhang, Lihua, et al.
Publicado: (2015)

Association of Hospital Payment Profiles With Variation in 30-Day Medicare Cost for Inpatients With Heart Failure or Pneumonia
por: Krumholz, Harlan M., et al.
Publicado: (2019)

Sex difference in incidence and risk factors of hospitalization for heart failure, and subsequent mortality: findings from the China PEACE million persons project
por: Qiu, Weida, et al.
Publicado: (2023)

Sex Differences in Clinical Profiles and Quality of Care Among Patients With ST‐Segment Elevation Myocardial Infarction From 2001 to 2011: Insights From the China Patient‐Centered Evaluative Assessment of Cardiac Events (PEACE)‐Retrospective Study
por: Du, Xue, et al.
Publicado: (2016)

National trends in hospital length of stay for acute myocardial infarction in China
por: Li, Qian, et al.
Publicado: (2015)

Influence of Spironolactone on Matrix Metalloproteinase-2 in Acute Decompensated Heart Failure
por: Ferreira, João Pedro, et al.
Publicado: (2015)

Phenotypes of heart failure with preserved ejection fraction and effect of spironolactone treatment
por: Choy, Manting, et al.
Publicado: (2022)

Variation in and Hospital Characteristics Associated With the Value of Care for Medicare Beneficiaries With Acute Myocardial Infarction, Heart Failure, and Pneumonia
por: Desai, Nihar R., et al.
Publicado: (2018)

Cost-Effectiveness Analysis of Patiromer and Spironolactone Therapy in Heart Failure Patients with Hyperkalemia
por: Bounthavong, Mark, et al.
Publicado: (2018)

Association of Racial and Socioeconomic Disparities With Outcomes Among Patients Hospitalized With Acute Myocardial Infarction, Heart Failure, and Pneumonia: An Analysis of Within- and Between-Hospital Variation
por: Downing, Nicholas S., et al.
Publicado: (2018)

Trajectories of Risk for Specific Readmission Diagnoses after Hospitalization for Heart Failure, Acute Myocardial Infarction, or Pneumonia
por: Krumholz, Harlan M., et al.
Publicado: (2016)

Association of the Hospital Readmissions Reduction Program With Mortality During and After Hospitalization for Acute Myocardial Infarction, Heart Failure, and Pneumonia
por: Khera, Rohan, et al.
Publicado: (2018)

Spotlight on Spironolactone Oral Suspension for the Treatment of Heart Failure: Focus on Patient Selection and Perspectives
por: Manolis, Antonis A, et al.
Publicado: (2019)

Hospital Strategy Uptake and Reductions in Unplanned Readmission Rates for Patients with Heart Failure: A Prospective Study
por: Bradley, Elizabeth H., et al.
Publicado: (2014)

Trajectories of risk after hospitalization for heart failure, acute myocardial infarction, or pneumonia: retrospective cohort study
por: Dharmarajan, Kumar, et al.
Publicado: (2015)

Design and rationale of the Cardiovascular Health and Text Messaging (CHAT) Study and the CHAT-Diabetes Mellitus (CHAT-DM) Study: two randomised controlled trials of text messaging to improve secondary prevention for coronary heart disease and diabetes
por: Huo, Xiqian, et al.
Publicado: (2017)

Spironolactone use is associated with improved outcomes in heart failure with mid‐range ejection fraction
por: Enzan, Nobuyuki, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_iuhk5h0j353d9d5dgdcroi7uga